clinical trial · NCT06557603
Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream
Humanis Saglık Anonim Sirketi·phase1·completed·n = 44
RosaceaIvermectin creamSoolantra ® (Ivermectin) cream
brief summary
Single dose bioequivalence study of Ivermectin 1% cream and Soolantra (Ivermectin) 10 mg/g cream in healthy adult human subjects.
started
Mar 6, 2024
primary completion
Jul 11, 2024
completion
Jul 22, 2024
last updated
Aug 20, 2024
detailed description
An open label, randomized, four-period, two treatment, two-sequence, fully replicate, crossover, balanced, single dose bioequivalence study.
official title
Single Dose Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream in Healthy Adult Human Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol